Decentralized clinical trials: Are we ready to make the leap?
- Recruiting and retaining patients for clinical trials has long been a problem.
- Currently, 85% of all clinical trials fail to recruit enough patients, 80% are delayed due to recruitment problems and dropout rates are high, says Rosamund Round Director, Patient Innovation Center at PAREXEL.
- According to the study, which examined approximately 4,000 phase II and phase III trials, patient-centric trials took an average of four months to recruit 100 participants, versus seven months for all types of trials.
- Currently, 70% of potential clinical trial patients live more than two hours from a study center, making participation in trials that require site visits less appealing.
- Next-gen technological innovations are just about ready to tackle this issue by enabling decentralized trials, says Nick Darwall-Smith, vice president, technology, at PAREXEL.
Read full article: biopharmadive.com